THE DRUG SAFETY RESEARCH TRUST
Post marketing surveillance of newly marketed medicines. Providing education and training in pharmacovigilance and related subjects.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net expenditure of £1,191,553 for the year, resulting in a decrease in total funds from £8,473,267 to £7,281,714. The trustees confirm that unrestricted free reserves of £6,866,214 are sufficient to cover ongoing costs and maintain stability, allowing the accounts to be prepared on a going concern basis.
What the accounts disclose
“£230,001 - £300,000 1” — page 27
“Donations and legacies 2 704,584 - 704,584 1,665,967” — page 18
“It is the policy of the charity to maintain unrestricted funds, which are the free reserves of the charity. This provides sufficient funds to cover the cost of ongoing studies, management and administration costs.” — page 10
“Other income represents management fees charged and donations received from the Trust's connected trading entity, DSRU Education and Research Limited.” — page 23
“Other income represents management fees charged and donations received from the Trust's connected trading entity, DSRU Education and Research Limited.” — page 23
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- PROFESSOR KENNETH ROSS PATERSONchair
- PROFESSOR ALAN JOHN CAMM QHP BSC
- PROFESSOR MARTIN PATTERSON VESSEY CBE FRCP
- Professor Allan Hunter Young
- Professor Isla Shelagh Mackenzie MBChB
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £1.2m | £2.5m |
| 31/12/2023 | £2.3m | £2.7m |
| 31/12/2022 | £1.9m | £2.7m |
| 31/12/2021 | £4.0m | £2.8m |
| 31/12/2020 | £1.4m | £1.6m |
Common questions
Is THE DRUG SAFETY RESEARCH TRUST financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net expenditure of £1,191,553 for the year, resulting in a decrease in total funds from £8,473,267 to £7,281,714. The trustees confirm that unrestricted free reserves of £6,866,214 are sufficient to cover ongoing costs and maintain stability, allowing the accounts to be prepared on a going concern basis. Its FY2024 accounts were audited by Cartwrights.
What does the highest-paid employee of THE DRUG SAFETY RESEARCH TRUST earn?
Per its FY2024 accounts, the highest-paid employee was in the £230,001 - £300,000 band.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| BEIS MENACHEM CHABAD LUBAVITCH | 1 | £183k |
| FOUNTAIN OF CHESSED LIMITED | 1 | £67k |
| YESHIVAS LUBAVITCH MANCHESTER | 1 | £20k |
| HAROFEH DONATIONS LIMITED | 1 | £16k |
| THE ALBERT GUBAY CHARITABLE FOUNDATION | 1 | £12k |
| DUCHY OF LANCASTER BENEVOLENT FUND | 1 | £5k |
Charities like this
- NARCONON TRUST
- BEIS HAMEDRASH SHAAREI TEFILLAH
- YAD VEACHISOMOCH L'CHAIM
- THE FACULTY OF PHARMACEUTICAL MEDICINE OF THE ROYAL COLLEGES OF PHYSICIANS OF THE UNITED KINGDOM
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- THE BRITISH ASSOCIATION OF DAY SURGERY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE DRUG SAFETY RESEARCH TRUST | £1.2m | £230,001 - £300,000 | — | above | — | no doubt |
| NARCONON TRUST | £179k | — | 0 | unclear | — | no doubt |
| BEIS HAMEDRASH SHAAREI TEFILLAH | £133k | — | 0 | above | — | no doubt |
| YAD VEACHISOMOCH L'CHAIM | £834k | — | 0 | unclear | — | no doubt |
| THE FACULTY OF PHARMACEUTICAL MEDICINE OF THE ROYAL COLLEGES OF PHYSICIANS OF THE UNITED KINGDOM | £2.2m | £70,001 - £80,000 | 2 | below | — | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £502k | — | 0 | above | — | no doubt |